Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-22-048555

Chief Medical Officer gave up 756 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eisner Mark Chief Medical Officer 2022-09-01 Shares withheld for taxes −756 $13.09 $9,896 149,044 D: show line 1 in the form
Loading xslF345X03/doc4.xml…